Alivira took part in the 2025 Brazil South Swine Symposium (SBSS), recognized as one of the most relevant technical and scientific forums in the sector. The event provided an excellent opportunity to connect with clients, friends, and partners. At SBSS 2025, Alivira officially launched Tulaject, a broad-spectrum tulathromycin for respiratory diseases in a single dose, reinforcing its commitment to delivering solutions that drive progress in the production chain. Special thanks to everyone who visited our booth and to the entire organizing team at Núcleo Oeste de Médicos Veterinários e Zootecnistas!
